tadalafil has been researched along with Airflow Obstruction, Chronic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goudie, AR; Hopkinson, PJ; Lipworth, BJ; Struthers, AD; Wei, L | 1 |
| Bednorz, M; Ghofrani, HA; Grimminger, F; Parajuli, N; Pichl, A; Schermuly, RT; Seeger, W; Seimetz, M; Weissmann, N | 1 |
| Ando, K; Hoshika, Y; Ienaga, H; Kimura, T; Kuraishi, H; Morio, Y; Nagaoka, T; Takahashi, K; Tsutsumi, T | 1 |
| van Driel, MF | 1 |
| Kim, HS; Lee, HB; Park, JH; Park, JK; Park, SJ | 1 |
1 review(s) available for tadalafil and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
[Phosphodiesterase inhibitors: effectiveness and new applications].
Topics: Carbolines; Coronary Disease; Erectile Dysfunction; Humans; Hypertension; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Prostatic Hyperplasia; Pulmonary Disease, Chronic Obstructive; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride | 2006 |
1 trial(s) available for tadalafil and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.
Topics: Aged; Carbolines; Double-Blind Method; Exercise Tolerance; Female; Humans; Hypertension, Pulmonary; Male; Phosphodiesterase 5 Inhibitors; Pulmonary Disease, Chronic Obstructive; Quality of Life; Scotland; Surveys and Questionnaires; Tadalafil; Treatment Outcome | 2014 |
3 other study(ies) available for tadalafil and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice.
Topics: Animals; Benzamides; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Hypertension, Pulmonary; Lung; Lung Compliance; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Phosphodiesterase 4 Inhibitors; Phosphodiesterase 5 Inhibitors; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyridines; Smoke; Smoking; Tadalafil | 2015 |
Potential Role of CT Metrics in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension.
Topics: Aged; Bosentan; Endothelin Receptor Antagonists; Exercise Test; Female; Forced Expiratory Volume; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Artery; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Sildenafil Citrate; Sulfonamides; Tadalafil; Tomography, X-Ray Computed; Vasodilator Agents; Vital Capacity | 2015 |
Use of tadalafil for treating pulmonary arterial hypertension secondary to chronic obstructive pulmonary disease.
Topics: Carbolines; Exercise Tolerance; Humans; Hypertension, Pulmonary; Male; Middle Aged; Oxygen Consumption; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Tadalafil | 2007 |